← Browse by Condition
Medical Condition

aortic stenosis

Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for aortic stenosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — aortic stenosis Clinical Trials

How many clinical trials are currently recruiting for aortic stenosis?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for aortic stenosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for aortic stenosis?
aortic stenosis research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a aortic stenosis clinical trial?
Eligibility criteria for aortic stenosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
Dermed Diagnostics, Inc. 1 trial
EmStop Inc 1 trial
University of Edinburgh 1 trial
Idoven 1903 S.L. 1 trial
University Hospital of Ferrara 1 trial

Recruiting Clinical Trials

NCT07230964
Recruiting
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
Enrollment
6 pts
Location
United States
Sponsor
Dermed Diagnostics, Inc.
View Trial →
NCT07276711
Recruiting
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
Enrollment
663 pts
Location
United States
Sponsor
EmStop Inc
View Trial →
NCT06047561
Recruiting
The Scottish Aortic Stenosis LongiTudinal Imaging and biomarkeR (SALTIRE) Programme
Enrollment
300 pts
Location
United Kingdom
Sponsor
University of Edinburgh
View Trial →
NCT07479992
Recruiting
Multicenter Study for the Validation of Willem AI: Aortic StenoSis Early Diagnosis With AI-electrocardiogram Study
Enrollment
5,000 pts
Location
Germany
Sponsor
Idoven 1903 S.L.
View Trial →
NCT07895719
Recruiting
Exercise and Diet Supplements for Older Patients Undergoing TAVI: the IRON-TAVI Trial
Enrollment
450 pts
Location
Italy
Sponsor
University Hospital of Ferrara
View Trial →
NCT07035847
Recruiting
Transaxillary TAVR With Solely Echocardiography Guidance
Enrollment
20 pts
Location
China
Sponsor
Chinese Academy of Medical Sci...
View Trial →
NCT06768008
Recruiting
An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease
Enrollment
10,000 pts
Location
China
Sponsor
Beijing Anzhen Hospital
View Trial →
NCT04552275 Phase 1
Recruiting
The HALT Biomarker Study
Enrollment
300 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT06722066
Recruiting
Impact of Aortic Annulus Calcification on Long-Term Outcomes Following Transcatheter Aortic Valve Replacement: SAINT-TAVR Calcium Registry
Enrollment
500 pts
Location
South Korea
Sponsor
Eunpyeong St. Mary's Hospital
View Trial →

Related Conditions

aortic valve stenosis (1) aortic valve disease (1) aortic stenosis disease (1) aortic stenosis symptomatic (1) congenital heart disease (1) coarctation of aorta (1) pulmonary atresia (1) pulmonary stenosis (1) transposition of the great arteries (1) truncus arteriosus (1) single ventricle (1) tetralogy of fallot tof (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology